Genmab’s data-driven strategies speed up drug commercialization

[Adobe Stock]

Genmab’s senior vice president, global head of data science and AI, Hisham Hamadeh, describes the company’s journey to becoming “a data-driven decision-making company.” In one sense, there is little choice but to do so. “We’re swimming in data like never before. We’ve seen the volumes of data, the ability to compute on that data, and the type of algorithms that are emerging,” he said. 

The initiative has the firm support of the company’s CEO Jan G. J. van de Winkel, who expects AI to help enhance R&D efficiency in the coming years. Already, the company has succeeded in winning FDA approval for the antibody epcoritamab in lymphoma within five years after the first patient was dosed. The approval timeline was “a world record,” van de Winkel told Medwatch, adding that the company believes its investments in data science will unlock further breakthrou…

Read more
  • 0

18 of the world’s most innovative medical technologies

[Images courtesy of Sysmex, Abbott, Boston Scientific, Medtronic and Siemens Healthineers]Judges this week are voting for the most innovative medical technologies among the nominees for the 2022 Prix Galien International Awards.

The Prix Galien International Awards highlight the most innovative technologies in the life sciences industry. The New York-based Galien Foundation presents the international award to eligible nominees that have received a Prix Galien award within the last two years in the Best Biotechnology Product, Best Digital Health Solution, Best Medical Technology, Best Pharmaceutical Product and Best Vaccine categories.

The Prix Galien International Awards ceremony will be co-hosted with the Prix Galien U.K. Award ceremony on May 12 at the Natural History Museum in London.

Companies included in this year’s nominees range from large multinational corporations like Medtronic to smaller medtech companies like Devices4Care. Here are the 18 medica…

Read more
  • 0

10 leading pharma executives you need to know

Pfizer CEO Dr. Albert Bourla [Image courtesy of Pfizer/Business Roundtable]Given the complexity of the pharmaceutical business, it can be challenging to gauge the performance of any chief executive in the space.

That said, CEOs’ annualized return over tenure as CEO over their term can hint at performance. In addition, rating sites like Glassdoor also indicate CEOs’ popularity.

Here, we parsed a range of metrics, including CEOs’ approval ratings, their ability to navigate the pandemic and their firms’ stock performance over time, to identify ten leading pharma executives.

Get the full story from our sister site, Drug Discovery & Development. 

Read more
  • 0